Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katsuya Shiraki

Showing results (1-10 of 219) with videos related to

Pageof 22
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 26, 2008
[General therapy of type C chronic hepatitis: efficacy and limitation of hepatoprotective agents]Katsuya Shiraki, Yoshiyuki Takei
The New England Journal of Medicine|July 19, 2008
Images in clinical medicine. Sclerosing peritonitisKatsuya Shiraki, Hiroyuki Sakurai
Liver International : Official Journal of the International Association for the Study of the Liver|September 7, 2006
Cytoplasmic p21(WAF1/CIP1) expression in human hepatocellular carcinomasKatsuya Shiraki, Hidetaka Wagayama
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 14, 2004
[Histological findings in the liver in patients with chronic hepatitis C]Koujirou Takase, Katsuya Shiraki
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 4, 2005
New serological markers for hepatocellular carcinomaKatsuya Shiraki, Koujiro Takase
Hepatology International|July 24, 2015
Different aspects of CD4 T cells that lead to viral clearance or persistence of HCV infectionKazushi Sugimoto, Katsuya Shiraki
Gastroenterology|May 15, 2003
Survivin in liverKatsuya Shiraki, Takeshi Nakano, Hisashi Hisatomi
Journal of Thrombosis and Haemostasis : JTH|June 5, 2020
The prothrombin time ratio is not a more effective marker for evaluating sepsis-induced coagulopathy than fibrin-related markersHideo Wada, Katsuya Shiraki, Motomu Shimaoka
Hepato-Gastroenterology|July 17, 2007
Serum interleukin-18 during liver regenerationKatsuya Shiraki, Yumi Yamaguchi, Shinji Uemoto
Journal of Thrombosis and Haemostasis : JTH|May 13, 2023
"Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis on sepsis-induced coagulopathy in the management of sepsis": Comment from Wada et alHideo Wada, Takeshi Matsumoto, Katsuya Shiraki
Pageof 22

Showing results (1-10 of 219) with videos related to

Sort By:
Pageof 22
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 26, 2008
[General therapy of type C chronic hepatitis: efficacy and limitation of hepatoprotective agents]Katsuya Shiraki, Yoshiyuki Takei
The New England Journal of Medicine|July 19, 2008
Images in clinical medicine. Sclerosing peritonitisKatsuya Shiraki, Hiroyuki Sakurai
Liver International : Official Journal of the International Association for the Study of the Liver|September 7, 2006
Cytoplasmic p21(WAF1/CIP1) expression in human hepatocellular carcinomasKatsuya Shiraki, Hidetaka Wagayama
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 14, 2004
[Histological findings in the liver in patients with chronic hepatitis C]Koujirou Takase, Katsuya Shiraki
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 4, 2005
New serological markers for hepatocellular carcinomaKatsuya Shiraki, Koujiro Takase
Hepatology International|July 24, 2015
Different aspects of CD4 T cells that lead to viral clearance or persistence of HCV infectionKazushi Sugimoto, Katsuya Shiraki
Gastroenterology|May 15, 2003
Survivin in liverKatsuya Shiraki, Takeshi Nakano, Hisashi Hisatomi
Journal of Thrombosis and Haemostasis : JTH|June 5, 2020
The prothrombin time ratio is not a more effective marker for evaluating sepsis-induced coagulopathy than fibrin-related markersHideo Wada, Katsuya Shiraki, Motomu Shimaoka
Hepato-Gastroenterology|July 17, 2007
Serum interleukin-18 during liver regenerationKatsuya Shiraki, Yumi Yamaguchi, Shinji Uemoto
Journal of Thrombosis and Haemostasis : JTH|May 13, 2023
"Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis on sepsis-induced coagulopathy in the management of sepsis": Comment from Wada et alHideo Wada, Takeshi Matsumoto, Katsuya Shiraki
Pageof 22